SCHEMBL8324831

SCHEMBL8324831

COC(=O)c1ccc(COS(C)(=O)=O)cn1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 2/20 0.51
PARP1 P09874 1/20 0.44
KDM4E B2RXH2 2/20 0.42
L3MBTL1 Q9Y468 2/20 0.42
PKM P14618 2/20 0.40
POLB P06746 1/20 0.39
DYRK1A Q13627 1/20 0.38
ALDH1A1 P00352 2/20 0.37
GABRP O00591 1/20 0.37
GABRD O14764 1/20 0.37
GABRA1 P14867 1/20 0.37
GABRB1 P18505 1/20 0.37
GABRG2 P18507 1/20 0.37
GABRB3 P28472 1/20 0.37
GABRA5 P31644 1/20 0.37
GABRA3 P34903 1/20 0.37
GABRA2 P47869 1/20 0.37
GABRB2 P47870 1/20 0.37
GABRA4 P48169 1/20 0.37
UBE2N P61088 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18496716 0.86 MAPK1 (0.49) MAPK1PARP1KDM4EL3MBTL1PKM
SCHEMBL28835625 0.85 P4HTM (0.54) MAPK1KDM4EL3MBTL1PKMPOLB
SCHEMBL2631699 0.83 MAPK1 (0.59) MAPK1PARP1KDM4EL3MBTL1PKM
SCHEMBL7883731 0.79 MAPK1 (0.62) MAPK1PARP1KDM4EL3MBTL1PKM
SCHEMBL507299 0.79 GRM2 (0.35) KDM4EL3MBTL1PKMPOLBALDH1A1
SCHEMBL10204398 0.78 ALDH1A1 (0.45) MAPK1PARP1KDM4EPKMALDH1A1
SCHEMBL8324962 0.78 MAPK1 (0.61) MAPK1PARP1KDM4EL3MBTL1PKM
SCHEMBL16452387 0.78 MAPK1 (0.53) MAPK1PARP1KDM4EL3MBTL1PKM
SCHEMBL1934998 0.77 HRH3 (0.50) L3MBTL1POLBALDH1A1NPC1RAB9A
SCHEMBL1437036 0.76 MAPK1 (0.59) MAPK1PARP1KDM4EL3MBTL1PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9682964-B2 Amide compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-06-20 US disclosed
US-9682964-B2 Amide compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-06-20 US disclosed
US-9682964-B2 Amide compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-06-20 US disclosed
US-20170144995-A1 AMIDE COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-05-25 US disclosed
US-20170144995-A1 AMIDE COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-05-25 US disclosed
US-20170144995-A1 AMIDE COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-05-25 US disclosed
WO-2014168052-A1 AMIDE COMPOUND 住友化学株式会社 (JP) 2014-10-16 WO disclosed
EP-0733033-B1 PHARMACEUTICALLY ACTIVE SUBSTITUTED AROMATIC COMPOUNDS ZENECA LTD (GB) 1999-12-22 EP disclosed
US-5811459-A PAIN RELIEVERS ZENECA LIMITED (GB) 1998-09-22 US disclosed
EP-0733033-A1 PHARMACEUTICALLY ACTIVE SUBSTITUTED AROMATIC COMPOUNDS ZENECA LIMITED (GB) 1996-09-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170144995-A1 AMIDE COMPOUND NAAA, AADAC, ACMSD MAPK1 3326/4885PARP1 4794/4885KDM4E 470/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.